Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection

H Kanegane1, H Wakiguchi, C Kanegane

  • 1Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan. kanegane@ms.toyama-mpu.ac.jp

Insights

High levels of Epstein-Barr virus (EBV) DNA in the blood are linked to fatal chronic active EBV infection. Detecting cell-free EBV DNA may help monitor disease severity.

Area of Science:

  • Virology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with various cancers and chronic conditions.
  • Chronic active EBV infection (CAEBV) is a severe condition with limited diagnostic markers.
  • Understanding EBV's role in CAEBV is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate the presence and significance of cell-free Epstein-Barr virus DNA in patients with chronic active EBV infection.
  • To compare EBV DNA levels in fatal vs. nonfatal CAEBV, acute infectious mononucleosis, and healthy controls.

Main Methods:

  • A cohort of 33 patients with chronic active EBV infection was studied.
  • The study included subgroups with fatal (n=14) and nonfatal (n=19) CAEBV, patients with acute infectious mononucleosis (n=18), and healthy controls (n=10).
  • Semiquantitative polymerase chain reaction (PCR) was used to detect and measure EBV DNA in serum or plasma samples.

Main Results:

  • EBV DNA was detected in 62% of patients with fatal CAEBV.
  • In contrast, only 11% of patients with nonfatal CAEBV and 11% with infectious mononucleosis tested positive for EBV DNA.
  • No EBV DNA was detected in healthy controls.

Conclusions:

  • Cell-free circulating EBV DNA is a significant indicator in chronic active EBV infection.
  • The presence of EBV DNA in serum/plasma may serve as a valuable biomarker for monitoring CAEBV severity.
  • Further research can explore EBV DNA as a prognostic tool for CAEBV outcomes.